About 20 percent of Air Force women deployed during the Iraq war report that they are experiencing at least one major symptom of post-traumatic stress disorder (PTSD), according to a University of Michigan survey of 1,114 servicewomen.
Understanding the molecular structures of compounds that give certain fruits and vegetables their rich colors may help researchers find even more powerful cancer fighters, a new study suggests.
Findings from a study released revealed that a limited amount of clinical research exists to prove the effectiveness of many over-the-counter (OTC) anti-aging products.
A team of entomologists from the North Carolina Department of Environment and Natural Resources has completed their assessment of the impact of mosquitoes following the flooding that occurred in southeast Kansas last month.
Addressing the Rotarians at the National Polio Plus Orientation and Planning Meet, after accepting the ‘Polio Eradication Champion Award’ the Indian Minister for Health & Family Welfare, Dr. Anbumamani Ramadoss said that the Government of India is fully committed to undertake all possible measures, notwithstanding the cost, for eradicating polio from the country.
Reclast? (zoledronic acid) Injection has been approved by the US Food and Drug Administration as the first and only once-yearly medicine for postmenopausal osteoporosis, offering an important new approach to the treatment of a bone disease affecting eight million women in the US.
Novartis announced today the availability in the US of the first shipments of Fluvirin influenza virus vaccine for the 2007/08 season.
With the State Children’s Health Insurance Program (SCHIP) set to expire Sept. 30, experts say that unless Congress and the White House reauthorize the program and agree on its funding, coverage for vulnerable children nationwide will be in jeopardy.
After performing an analysis of school shootings in the last decade, researchers at the Shyness Research Institute in Indiana say that the perpetrators are likely to suffer from cynical shyness — an extreme form of shyness that predominantly affects males and can lead to violent behavior.
Dendreon Corporation (Nasdaq: DNDN) announced publication of results from a Phase 1 study of NEUVENGE, an investigational active cellular immunotherapy, in the August 20 issue of the Journal of Clinical Oncology.